News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
234,771 Results
Type
Article (18951)
Company Profile (161)
Press Release (215656)
Multimedia
Podcasts (50)
Webinars (6)
Section
Business (62037)
Career Advice (198)
Deals (9067)
Drug Delivery (63)
Drug Development (34130)
Employer Resources (34)
FDA (6874)
Job Trends (6281)
News (112772)
Policy (11439)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1593)
Academic (1)
Accelerated approval (20)
Adcomms (13)
Allergies (75)
Alliances (17873)
ALS (78)
Alzheimer's disease (740)
Antibody-drug conjugate (ADC) (143)
Approvals (7166)
Artificial intelligence (274)
Autoimmune disease (94)
Automation (18)
Bankruptcy (55)
Best Places to Work (5992)
BIOSECURE Act (7)
Biosimilars (137)
Biotechnology (112)
Bladder cancer (93)
Brain cancer (25)
Breast cancer (325)
Cancer (2478)
Cardiovascular disease (258)
Career advice (184)
Career pathing (7)
CAR-T (154)
CDC (17)
Celiac Disease (1)
Cell therapy (424)
Cervical cancer (13)
Clinical research (30416)
Collaboration (976)
Company closure (1)
Compensation (407)
Complete response letters (23)
COVID-19 (1146)
CRISPR (72)
C-suite (468)
Cystic fibrosis (94)
Data (3666)
Decentralized trials (1)
Denatured (22)
Depression (68)
Diabetes (279)
Diagnostics (2356)
Digital health (24)
Diversity (8)
Diversity, equity & inclusion (13)
Drug discovery (152)
Drug pricing (119)
Drug shortages (19)
Duchenne muscular dystrophy (138)
Earnings (20412)
Editorial (25)
Employer branding (2)
Employer resources (35)
Events (35569)
Executive appointments (493)
FDA (8609)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (12)
Funding (664)
Gene editing (144)
Generative AI (28)
Gene therapy (368)
GLP-1 (550)
Government (1718)
Grass and pollen (2)
Guidances (170)
Healthcare (7672)
HIV (44)
Huntington's disease (25)
IgA nephropathy (54)
Immunology and inflammation (102)
Immuno-oncology (32)
Indications (71)
Infectious disease (1282)
Inflammatory bowel disease (129)
Inflation Reduction Act (7)
Influenza (57)
Intellectual property (83)
Interviews (14)
IPO (4372)
IRA (28)
Job creations (724)
Job search strategy (167)
JPM (33)
Kidney cancer (11)
Labor market (18)
Layoffs (145)
Leadership (8)
Legal (1809)
Liver cancer (41)
Longevity (7)
Lung cancer (352)
Lymphoma (242)
Machine learning (21)
Management (11)
Manufacturing (401)
MASH (95)
Medical device (2674)
Medtech (2688)
Mergers & acquisitions (5130)
Metabolic disorders (712)
Multiple sclerosis (79)
NASH (12)
Neurodegenerative disease (154)
Neuropsychiatric disorders (40)
Neuroscience (1369)
NextGen: Class of 2026 (2141)
Non-profit (1717)
Now hiring (16)
Obesity (340)
Opinion (100)
Ovarian cancer (83)
Pain (114)
Pancreatic cancer (97)
Parkinson's disease (132)
Partnered (14)
Patents (156)
Patient recruitment (243)
Peanut (24)
People (23279)
Pharmaceutical (33)
Pharmacy benefit managers (15)
Phase 1 (8476)
Phase 2 (12307)
Phase 3 (11892)
Pipeline (2761)
Policy (153)
Postmarket research (1436)
Preclinical (3342)
Press Release (15)
Prostate cancer (125)
Psychedelics (16)
Radiopharmaceuticals (162)
Rare diseases (516)
Real estate (1569)
Recruiting (12)
Regulatory (10366)
Reports (13)
Research institute (1400)
Resumes & cover letters (17)
Rett syndrome (24)
RNA editing (11)
RSV (34)
Schizophrenia (80)
Series A (129)
Series B (102)
Sickle cell disease (76)
Special edition (8)
Spinal muscular atrophy (91)
Sponsored (18)
Startups (1382)
Stomach cancer (7)
Supply chain (49)
Tariffs (52)
The Weekly (27)
Vaccines (414)
Venture capital (44)
Weight loss (221)
Women's health (42)
Worklife (1)
Date
Today (92)
Last 7 days (281)
Last 30 days (1057)
Last 365 days (14083)
2026 (1819)
2025 (14141)
2024 (15467)
2023 (16756)
2022 (20921)
2021 (21719)
2020 (19864)
2019 (17103)
2018 (12836)
2017 (12038)
2016 (11195)
2015 (12070)
2014 (8474)
2013 (6958)
2012 (7042)
2011 (7012)
2010 (5678)
Location
Africa (245)
Alabama (30)
Alaska (1)
Arizona (61)
Arkansas (3)
Asia (15837)
Australia (2169)
California (5044)
Canada (1162)
China (587)
Colorado (164)
Connecticut (251)
Delaware (232)
Europe (35592)
Florida (698)
Georgia (135)
Hawaii (1)
Idaho (15)
Illinois (406)
India (38)
Indiana (333)
Iowa (6)
Japan (322)
Kansas (55)
Kentucky (9)
Louisiana (11)
Maine (28)
Maryland (504)
Massachusetts (4183)
Michigan (48)
Minnesota (131)
Mississippi (1)
Missouri (65)
Montana (9)
Nebraska (4)
Nevada (31)
New Hampshire (14)
New Jersey (1743)
New Mexico (11)
New York (1428)
North Carolina (657)
North Dakota (6)
Northern California (2659)
Ohio (124)
Oklahoma (5)
Oregon (22)
Pennsylvania (989)
Puerto Rico (4)
Rhode Island (17)
South America (301)
South Carolina (8)
Southern California (1831)
Tennessee (47)
Texas (601)
United States (18233)
Utah (154)
Vermont (1)
Virginia (135)
Washington D.C. (44)
Washington State (431)
Wisconsin (51)
234,771 Results for "ambys medicines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BeOne Medicines to Present at Upcoming March 2026 Investor Conferences
February 17, 2026
·
2 min read
Press Releases
Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology
February 9, 2026
·
4 min read
Press Releases
Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines
January 5, 2026
·
3 min read
Press Releases
InSysBio to announce a new collaborative project with BeOne Medicines
January 28, 2026
·
1 min read
Press Releases
ACTG Announces Publication of LATITUDE Findings in the New England Journal of Medicine
February 18, 2026
·
5 min read
Press Releases
Precision for Medicine Broadens Global Footprint with Singapore Office Opening
February 5, 2026
·
3 min read
GLP-1
WHO Adds GLP-1s to List of Essential Medicines
The World Health Organization’s Essential Medicines list guides high-level procurement and coverage decisions for over 150 countries.
September 8, 2025
·
2 min read
·
Tristan Manalac
Business
Ambys Medicines Expands Leadership Team with Key Appointments in Human Resources and Finance Functions
Ambys Medicines, a company pioneering cell-replacement therapies for patients with liver failure, today announced the expansion of its leadership team with the appointments of Samira Shaikhly as Chief Human Resources Officer and John McKeon as Vice President of Finance.
April 20, 2022
·
3 min read
Business
Ambys Medicines Appoints Dr. Corinne Foo-Atkins as Chief Strategy Officer
Ambys Medicines, a company pioneering cell-based therapies for severe liver diseases, today announced the appointment of Corinne Foo-Atkins, MBBS, MBA, MSc, as the company’s first Chief Strategy Officer.
January 20, 2022
·
3 min read
Press Releases
Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026
February 5, 2026
·
1 min read
1 of 23,478
Next
